1. 211 SPANISH REGISTRY OF ERYTHROPOIETIC STIMULATING AGENTS STUDY: THE LARGEST RETROSPECTIVE STUDY OF ESAS FOR THE TREATMENT OF ANEMIA IN LOWER RISK MDS PATIENTS. Issue 1 (April 2015) Authors: Campelo, M. Diez; Lorenzo, J.I.; Benlloch, L.; Lopez-Pavia, M.; Such, E.; Bernal, T.; Luño, E.; Davila, J.; Ramos, F.; Calabuig, M.; Pomares, H.; Gonzalez, B.; Merchan, B.; Barranco, E.; Tello, R. Sancho; Callejas, M.; Requena, M.J.; Jimenez, M.J.; Pedreño, M.; Vicente, A.I. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 213 AZACITIDINE (AZA) IN HIGHER RISK MDS PATIENTS WITH CHROMOSOME 7 ABNORMALITIES (ABN 7): RESULTS OF A RETROSPECTIVE STUDY FROM THE GFM AND GESMD REGISTRIES. Issue 1 (April 2015) Authors: Campelo, M. Díez; Lorenzo, J.I.; Itzykson, R.; Rojas, S.M.; Berthon, C.; Luño, E.; Beyne-Rauzy, O.; Pérez-Oteyza, J.; Vey, N.; Bargay, J.; Park, S.; Cedena, T.; Bordessoule, D.; Muñoz, J.A.; Gyan, E.; Such, E.; Visanica, S.; Benlloch, L.; de Botton, S.; Hernández-Rivas, J.M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine Improves Outcome in High Risk MDS Patients with Chromosome 7 Abnormalities: Retrospective Comparison of GESMD and GFM Registries. (April 2017) Authors: Díez Campelo, M.E.; Lorenzo, J.I.; Itzykson, R.; Rojas, S.M.; Berthon, C.; Pérez-Oteiza, J.; Beyne-Rauzy, O.; Bargay, J.; Vey, N.; Cedena, T.; Park, S.; Such, E.; Bordessoule, D.; Hernández Rivas, J.M.; López Cadenas, F.; Cañizo, M.C.; Fenaux, P. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗